Heron Therapeutics | Aktuelle Verpflichtungen

Aktienkurs
1.30
Täglich Wechseln
0.02 1.17%
Monatlich
-13.09%
Jährlich
-21.99%
Q1 Prognose
2.71




Aktuelle Verpflichtungen Veränderung Datum
ALKERMES USD 474.36M 31.6M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
Amarin USD 182.23M 3.71M 2025-09
ANI Pharmaceuticals USD 270.56M 33.72M 2025-09
Anika Therapeutics USD 19.09M 3.01M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
Eisai JPY 387.67B 9.42B 2025-12
Esperion Therapeutics USD 359.03M 60.24M 2025-09
GlaxoSmithKline GBP 21.39B 57M 2025-12
Heron Therapeutics USD 89.71M 168.89M 2025-09
Insmed USD 417.21M 105.53M 2025-09
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neurocrine Biosciences USD 638M 91.7M 2025-09
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 107.08M 206.09M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Surmodics USD 20.54M 347K 2024-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Veracyte USD 72.15M 4.28M 2025-09
Vertex Pharmaceuticals USD 4.48B 336.9M 2025-09


Heron Therapeutics Aktuelle Verpflichtungen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.